Abilify and Obesity - a phase IV clinical study of FDA data
Summary:
Obesity is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Seroquel, and have Schizophrenia.
The phase IV clinical study analyzes which people have Obesity when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.
What is Obesity?
Obesity (having too much body fat) is found to be associated with 1,947 drugs and 2,304 conditions by eHealthMe. Check the latest studies of Obesity.
97,308 people reported to have side effects when taking Abilify.
Among them, 1,430 people (1.47%) have Obesity.

Among these 1,430 people:
How long have people been on Abilify when they have Obesity? *
What is the gender of people who have Obesity when taking Abilify? *
What is the age of people who have Obesity when taking Abilify? *
What are other drugs people take besides Abilify? *
What are other side effects people have besides Obesity? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Obesity?
- Check whether Obesity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,450 reports)
Obesity treatments and more:
- Obesity (62,423 reports)
How severe was Obesity and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
- Obesity and drugs with ingredients of aripiprazole (1,780 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Obesity:
- Obesity (1,947 drugs)
Browse all the conditions that are associated with Obesity:
- Obesity (2,304 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Onglyza vs. Metformin, side effect and effectiveness comparison - 3 seconds ago
- Nisoldipine vs. Levothyroxine Sodium, side effect and effectiveness comparison - 8 seconds ago
- Paroxysmal Nocturnal Haemoglobinuria and Drug Abuse And Dependence - 23 seconds ago
- Could Calcitriol cause Carpal Tunnel Syndrome? - 26 seconds ago
- Could Calan cause Blood Potassium Decreased? - 27 seconds ago
- Could Alendronate Sodium cause Vasculitis? - 31 seconds ago
- Hydrocodone Bitartrate vs. Tizanidine Hydrochloride, side effect and effectiveness comparison - 33 seconds ago
- Erythromycin Stearate vs. Epiduo, side effect and effectiveness comparison - 37 seconds ago
- Pain In Extremity and Pruritus Generalised - 39 seconds ago
- Drug interactions of Hydroxyzine Hydrochloride and Methadone Hydrochloride - 40 seconds ago